Middle East Veterinary Vaccines Market

Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026

Ask The Analyst Customization Available Request Methodology

Attenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period

Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0. 

Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines

Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments. 

There are international guidelines on the usage of livestock identification and traceability systems (LITS) for better herd management, identifying zoonosis and managing animal health and incorporating food safety. However, most countries in the MEA region fail to implement proper LITS thereby affecting effective animal disease management. This is expected to fuel the demand for protective maintenance of animal health through early attenuated live vaccinations in order to avoid the spread of infectious diseases. The countries within the MEA region and Central Europe are increasingly dependent on live stock trading as a means of survival. Furthermore, in order to address chronic food insecurity in rural areas, animals are transferred from one place to another. This is fuelling demand for adequate vaccinations as an infection affecting one of the herds could easily spread to another and lead to mass losses. This factor is creating a positive impact on attenuated live vaccinations in the region. 

Attenuated live vaccines are expected to witness increased demand throughout the forecast period in Jordan 

The attenuated live vaccines segment is expected to witness a significant CAGR given greater adoption in commercial farms in the UAE veterinary vaccines market. Lower dosages and repetition are factors that are expected to contribute towards greater demand for attenuated live vaccines among all animal segments in Turkey. In Jordan, attenuated live vaccines are expected to witness increased demand throughout the forecast period. Lack of organised animal rearing and tracking practices hinder estimation of demand for attenuated live vaccines in Sudan.  

middle east veterinary vaccines market

Scenario of Local Manufacturing and Veterinary Vaccine Registration 

“The MEA region accounts for a vast livestock population; however, it is largely dependent on imports for the supply of adequate veterinary vaccines. Only six countries have the facility to produce vaccines locally. These include Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey. Local produce acceptance is higher as regulatory authorities have relatively fewer requirements for local vaccines than imported ones. The time duration for imported vaccines to obtain the required registration is also longer. Only four countries follow the international norms of OIE although the OIE has not yet established official international standards in this respect.”

--- Analyst – Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights

Our expert team of analysts provide in-depth information about the various strategies adopted by the key players in the Middle East veterinary vaccines market in a new report published by Future Market Insights titled “Veterinary Vaccines Market: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026.” According to the analysts, a market player can clearly gain an advantage in terms of correct demand estimation, if it has the local presence in terms of an office set up and resources, especially to tap sudden outbreaks such as Avian Influenza. After studying the market in detail, we found that the bigger the product portfolio, the greater the ability to operate at an intra-regional level and maintaining a healthy distributor portfolio is the key to garner higher margins, product visibility and sales. We have analysed that intense competition among existing players leads comparable players to increase their available product portfolio. We have also considered the overall market approach and have come to a conclusion that veterinarians and private veterinary pharmacies are key stakeholders in the sales and distribution of essential veterinary vaccines.

We have done a comprehensive analysis of target geographies which provides a 360o forecast of various countries in the Middle East. According to our team of experts, Turkey, Egypt, UAE, and Jordan are the key markets in the MEA region. Apart from this, our extensive research focusses on distributors, who play the most important role in the route-to-market chain as the markets are largely dependent on imported vaccines. Players in the market are also concentrating on the formation of formal vaccination schedules and harmonisation of registration guidelines. A consistent marketing approach on bovine and poultry vaccines is expected which are generally administered annually or biannually.

Value chain analysis with insights on essential vaccines is the uniqueness of this report

Our exclusive report on the Middle East veterinary vaccines market starts with an overview of the parent market of veterinary vaccines. The presence of a large number of livestock animals, communal herding practices, and lack of domestic testing and vaccine manufacturing facilities are factors garnering interest in the Middle East veterinary vaccines market from industry heavyweights. We have covered the Middle East veterinary vaccines market performance in terms of revenue, followed by drivers and restraints from the supply and demand perspectives. This is followed by trends and opportunities in the Middle East veterinary vaccines market. While examining the value chain of the Middle East veterinary vaccines market, we have offered pertinent insights on the following key points: 

  • Animal product supply chains are complex in nature in most Middle Eastern markets

  • Supply chains are directly dependent on product registration and authorisation norms of individual countries

  • Exceptional stakeholders such as pet shops and pet shelters could be present in case of distribution of animal vaccines

  • For fisheries, the aquaculture association of individual countries could play a pivotal role 

The competitive landscape has been included in this report to provide a dashboard view of key companies operating in the Middle East veterinary vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the Middle East veterinary vaccines market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the Middle East veterinary vaccines market. Detailed profiles of veterinary vaccines manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies.

Middle East Veterinary Vaccines Market: Segmentation

By Country

By Vaccine Type

By Disease Indication

By Animal Type

By Distribution Channel

  • United Arab Emirates

  • Kingdom of Saudi Arabia

  • Turkey

  • Jordan

  • Sudan

  • Egypt

  • Rest of MEA

 

  • Attenuated Live Vaccines

  • Inactivated Vaccines

  • Toxoid Vaccines

  • DNA Vaccines

  • Recombinant Vaccines

  • Others

 

  • Foot and Mouth Disease

  • New Castle Disease

  • PPRS

  • Canine Parvovirus

  • Brucellosis

  • Avian Influenza

  •  Others

 

  • Companion Animals

    • Canine

    • Avian

    • Feline

  • Livestock Animals

    • Aquatic

    • Bovine

    • Porcine

    • Small Ruminant

    • Poultry

  • Equine

  • Hospital Pharmacies

  • Veterinary Clinics

  • Private Veterinary Pharmacies

  • Others

Extensive primary and secondary research to quantify market numbers

The forecast presented for the Middle East veterinary vaccines market assesses the total revenue generated in the Middle East veterinary vaccines market. While developing the forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome based on an analysis of supply side and demand side factors. For quantifying the market numbers, we have conducted extensive interviews with subject matter experts in the Middle East veterinary vaccines market. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the Middle East veterinary vaccines market.

As previously mentioned, the MEA veterinary vaccines market is split into various segments and all these segments have been analysed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the Middle East veterinary vaccines market.

Another key feature of this report is the analysis of the Middle East veterinary vaccines market by vaccine type, animal type, end user, disease indication and country; and the corresponding market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity analysis is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the Middle East veterinary vaccines market.

Middle East Veterinary Vaccines Market Reports - Table of Contents

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Middle East Veterinary Vaccines Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

3.2. Market Overview

3.2.1. Value Chain

4. Market Dynamics and USPs

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5.Standard Approval Process U.S.

4.6.Vaccines Labelling Requirements

4.7.Scenario of Local Manufacturing and Veterinary Vaccine Registration

4.8.Veterinary Medical Product Registration Timelines and Products

5. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Vaccine Type 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Vaccine Type 

5.3. Y-o-Y Growth Projections By Vaccine Type 

5.4. Market Value Forecast By Vaccine Type, 2016–2026

5.4.1. Live Attenuated Vaccines

5.4.2. Killed/Inactive Vaccines

5.4.3. Recombinant Vaccines

5.4.4. DNA Vaccines

5.4.5. Toxoid Vaccines

5.4.6. Others

5.5. Market Attractiveness By Vaccine Type 

6. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Animal Type 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Animal Type 

6.3. Y-o-Y Growth Projections By Animal Type 

6.4. Market Value Forecast By Animal Type, 2016–2026

6.4.1. Companion Animal 

6.4.1.1. Canine

6.4.1.2. Feline

6.4.1.3. Avian (Ornamental Bird)

6.4.2. Livestock Animal 

6.4.2.1. Aquatic

6.4.2.2. Bovine

6.4.2.3. Porcine

6.4.2.4. Small Ruminant

6.4.2.5. Poultry

6.4.3. Equine

6.5. Market Attractiveness By Animal Type 

7. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Disease Indication 

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Disease Indication 

7.3. Y-o-Y Growth Projections By Disease Indication 

7.4. Market Value Forecast By Disease Indication, 2016–2026

7.4.1. Foot and Mouth Diseases

7.4.2. Avian Influenza

7.4.3. New Castle Disease 

7.4.4. PPRS

7.4.5. Brucellosis

7.4.6. Canine Parvovirus

7.4.7. Others

7.5. Market Attractiveness By Disease Indication 

8. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Distribution Channel 

8.1. Introduction

8.2. Basis Point Share (BPS) Analysis By Distribution Channel 

8.3. Y-o-Y Growth Projections By Distribution Channel 

8.4. Market Value Forecast By Distribution Channel, 2016–2026

8.4.1. Hospital Pharmacies

8.4.2. Veterinary Clinics

8.4.3. Private Veterinary Pharmacies

8.4.4. Others ( Research Institutes, Laboratories) 

8.5. Market Attractiveness By Distribution Channel 

9. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Country

9.1. Basis Point Share (BPS) Analysis By Country

9.2. Y-o-Y Growth Projections By Country

9.3. Market Value Forecast By Country

9.3.1. UAE

9.3.2. KSA

9.3.3. Turkey

9.3.4. Jordan

9.3.5. Sudan

9.3.6. Egypt

9.3.7. Rest of MEA

9.4. Market Attractiveness By Country

10. UAE Veterinary Vaccines Market Analysis and Forecast

10.1.Market Value Forecast By Vaccine Type, 2016–2026

10.1.1. Live Attenuated Vaccines

10.1.2. Killed/Inactive Vaccines

10.1.3. Recombinant Vaccines

10.1.4. DNA Vaccines

10.1.5. Toxoid Vaccines

10.1.6. Others

10.2.Market Value Forecast By Disease Indication, 2016–2026

10.2.1. Foot and Mouth Diseases

10.2.2. Avian Influenza

10.2.3. New Castle Disease 

10.2.4. PPRS

10.2.5. Brucellosis

10.2.6. Canine Parvovirus

10.2.7. Others

10.3.Market Value Forecast By Animal Type, 2016–2026

10.3.1. Companion Animal 

10.3.1.1. Canine

10.3.1.2. Feline

10.3.1.3. Avian (Ornamental Bird)

10.3.2. Livestock Animal 

10.3.2.1. Aquatic

10.3.2.2. Bovine

10.3.2.3. Porcine

10.3.2.4. Small Ruminant

10.3.2.5. Poultry

10.3.3. Equine

10.4.Market Value Forecast By Distribution Channel, 2016–2026

10.4.1. Hospital Pharmacies

10.4.2. Veterinary Clinics

10.4.3. Private Veterinary Pharmacies

10.4.4. Others ( Research Institutes, Laboratories) 

11. KSA Veterinary Vaccines Market Analysis and Forecast

11.1.Market Value Forecast By Vaccine Type, 2016–2026

11.1.1. Live Attenuated Vaccines

11.1.2. Killed/Inactive Vaccines

11.1.3. Recombinant Vaccines

11.1.4. DNA Vaccines

11.1.5. Toxoid Vaccines

11.1.6. Others

11.2.Market Value Forecast By Disease Indication, 2016–2026

11.2.1. Foot and Mouth Diseases

11.2.2. Avian Influenza

11.2.3. New Castle Disease 

11.2.4. PPRS

11.2.5. Brucellosis

11.2.6. Canine Parvovirus

11.2.7. Others

11.3.Market Value Forecast By Animal Type, 2016–2026

11.3.1. Companion Animal 

11.3.1.1. Canine

11.3.1.2. Feline

11.3.1.3. Avian (Ornamental Bird)

11.3.2. Livestock Animal 

11.3.2.1. Aquatic

11.3.2.2. Bovine

11.3.2.3. Porcine

11.3.2.4. Small Ruminant

11.3.2.5. Poultry

11.3.3. Equine

11.4.Market Value Forecast By Distribution Channel, 2016–2026

11.4.1. Hospital Pharmacies

11.4.2. Veterinary Clinics

11.4.3. Private Veterinary Pharmacies

11.4.4. Others ( Research Institutes, Laboratories) 

12. Turkey Veterinary Vaccines Market Analysis and Forecast

12.1.Market Value Forecast By Vaccine Type, 2016–2026

12.1.1. Live Attenuated Vaccines

12.1.2. Killed/Inactive Vaccines

12.1.3. Recombinant Vaccines

12.1.4. DNA Vaccines

12.1.5. Toxoid Vaccines

12.1.6. Others

12.2.Market Value Forecast By Disease Indication, 2016–2026

12.2.1. Foot and Mouth Diseases

12.2.2. Avian Influenza

12.2.3. New Castle Disease 

12.2.4. PPRS

12.2.5. Brucellosis

12.2.6. Canine Parvovirus

12.2.7. Others

12.3.Market Value Forecast By Animal Type, 2016–2026

12.3.1. Companion Animal 

12.3.1.1. Canine

12.3.1.2. Feline

12.3.1.3. Avian (Ornamental Bird)

12.3.2. Livestock Animal 

12.3.2.1. Aquatic

12.3.2.2. Bovine

12.3.2.3. Porcine

12.3.2.4. Small Ruminant

12.3.2.5. Poultry

12.3.3. Equine

12.4.Market Value Forecast By Distribution Channel, 2016–2026

12.4.1. Hospital Pharmacies

12.4.2. Veterinary Clinics

12.4.3. Private Veterinary Pharmacies

12.4.4. Others ( Research Institutes, Laboratories) 

13. Jordan Veterinary Vaccines Market Analysis and Forecast

13.1.Market Value Forecast By Vaccine Type, 2016–2026

13.1.1. Live Attenuated Vaccines

13.1.2. Killed/Inactive Vaccines

13.1.3. Recombinant Vaccines

13.1.4. DNA Vaccines

13.1.5. Toxoid Vaccines

13.1.6. Others

13.2.Market Value Forecast By Disease Indication, 2016–2026

13.2.1. Foot and Mouth Diseases

13.2.2. Avian Influenza

13.2.3. New Castle Disease 

13.2.4. PPRS

13.2.5. Brucellosis

13.2.6. Canine Parvovirus

13.2.7. Others

13.3.Market Value Forecast By Animal Type, 2016–2026

13.3.1. Companion Animal 

13.3.1.1. Canine

13.3.1.2. Feline

13.3.1.3. Avian (Ornamental Bird)

13.3.2. Livestock Animal 

13.3.2.1. Aquatic

13.3.2.2. Bovine

13.3.2.3. Porcine

13.3.2.4. Small Ruminant

13.3.2.5. Poultry

13.3.3. Equine

13.4.Market Value Forecast By Distribution Channel, 2016–2026

13.4.1. Hospital Pharmacies

13.4.2. Veterinary Clinics

13.4.3. Private Veterinary Pharmacies

13.4.4. Others ( Research Institutes, Laboratories) 

14. Sudan Veterinary Vaccines Market Analysis and Forecast

14.1.Market Value Forecast By Vaccine Type, 2016–2026

14.1.1. Live Attenuated Vaccines

14.1.2. Killed/Inactive Vaccines

14.1.3. Recombinant Vaccines

14.1.4. DNA Vaccines

14.1.5. Toxoid Vaccines

14.1.6. Others

14.2.Market Value Forecast By Disease Indication, 2016–2026

14.2.1. Foot and Mouth Diseases

14.2.2. Avian Influenza

14.2.3. New Castle Disease 

14.2.4. PPRS

14.2.5. Brucellosis

14.2.6. Canine Parvovirus

14.2.7. Others

14.3.Market Value Forecast By Animal Type, 2016–2026

14.3.1. Companion Animal 

14.3.1.1. Canine

14.3.1.2. Feline

14.3.1.3. Avian (Ornamental Bird)

14.3.2. Livestock Animal 

14.3.2.1. Aquatic

14.3.2.2. Bovine

14.3.2.3. Porcine

14.3.2.4. Small Ruminant

14.3.2.5. Poultry

14.3.3. Equine

14.4.Market Value Forecast By Distribution Channel, 2016–2026

14.4.1. Hospital Pharmacies

14.4.2. Veterinary Clinics

14.4.3. Private Veterinary Pharmacies

14.4.4. Others ( Research Institutes, Laboratories) 

15. Egypt Veterinary Vaccines Market Analysis and Forecast

15.1.Market Value Forecast By Vaccine Type, 2016–2026

15.1.1. Live Attenuated Vaccines

15.1.2. Killed/Inactive Vaccines

15.1.3. Recombinant Vaccines

15.1.4. DNA Vaccines

15.1.5. Toxoid Vaccines

15.1.6. Others

15.2.Market Value Forecast By Disease Indication, 2016–2026

15.2.1. Foot and Mouth Diseases

15.2.2. Avian Influenza

15.2.3. New Castle Disease 

15.2.4. PPRS

15.2.5. Brucellosis

15.2.6. Canine Parvovirus

15.2.7. Others

15.3.Market Value Forecast By Animal Type, 2016–2026

15.3.1. Companion Animal 

15.3.1.1. Canine

15.3.1.2. Feline

15.3.1.3. Avian (Ornamental Bird)

15.3.2. Livestock Animal 

15.3.2.1. Aquatic

15.3.2.2. Bovine

15.3.2.3. Porcine

15.3.2.4. Small Ruminant

15.3.2.5. Poultry

15.3.3. Equine

15.4.Market Value Forecast By Distribution Channel, 2016–2026

15.4.1. Hospital Pharmacies

15.4.2. Veterinary Clinics

15.4.3. Private Veterinary Pharmacies

15.4.4. Others ( Research Institutes, Laboratories) 

16. Rest of MEA Veterinary Vaccines Market Analysis and Forecast

16.1.Market Value Forecast By Vaccine Type, 2016–2026

16.1.1. Live Attenuated Vaccines

16.1.2. Killed/Inactive Vaccines

16.1.3. Recombinant Vaccines

16.1.4. DNA Vaccines

16.1.5. Toxoid Vaccines

16.1.6. Others

16.2.Market Value Forecast By Disease Indication, 2016–2026

16.2.1. Foot and Mouth Diseases

16.2.2. Avian Influenza

16.2.3. New Castle Disease 

16.2.4. PPRS

16.2.5. Brucellosis

16.2.6. Canine Parvovirus

16.2.7. Others

16.3.Market Value Forecast By Animal Type, 2016–2026

16.3.1. Companion Animal 

16.3.1.1. Canine

16.3.1.2. Feline

16.3.1.3. Avian (Ornamental Bird)

16.3.2. Livestock Animal 

16.3.2.1. Aquatic

16.3.2.2. Bovine

16.3.2.3. Porcine

16.3.2.4. Small Ruminant

16.3.2.5. Poultry

16.3.3. Equine

16.4.Market Value Forecast By Distribution Channel, 2016–2026

16.4.1. Hospital Pharmacies

16.4.2. Veterinary Clinics

16.4.3. Private Veterinary Pharmacies

16.4.4. Others ( Research Institutes, Laboratories) 

17. Competition Landscape

17.1. Competition Dashboard

17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

17.2.1. JOVAC 

17.2.2. Bioveta, Inc. 

17.2.3. Intervac Pvt. Ltd.

17.2.4. Zoetis 

17.2.5. Elanco 

17.2.6. Merial 

17.2.7. Merck & Co., Inc. 

17.2.8. Bayer Pharma AG 

17.2.9. Ceva 

18. Assumptions and Acronyms Used

19. Research Methodology

Middle East Veterinary Vaccines Market Reports - List of Tables

Table 1: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 2: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 3: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 4: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 5: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026

Table 6: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 7: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 8: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 9: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 10: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 11: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 12: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 13: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 14: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 15: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 16: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 17: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 18: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 19: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 20: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 21: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 22: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 23: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 24: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 25: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 26: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 27: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 28: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 29: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Table 30: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026

Table 31: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026

Table 32: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026

Table 33: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

Middle East Veterinary Vaccines Market Reports - List of Figures

Figure 01: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast 2016 and 2026

Figure 02: Middle East Veterinary Vaccines Market Value Share, By Vaccine Type, 2016

Figure 03: Middle East Veterinary Vaccines Market Value Share, By Animal Type, 2016

Figure 04: Middle East Veterinary Vaccines Market Value Share, By Disease Indication, 2016

Figure 05: Middle East Veterinary Vaccines Market Value Share, By End User, 2016

Figure 06: Middle East Veterinary Vaccines Market Value Share, By Country, 2016

Figure 07: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast, 2015–2026 

Figure 08: Middle East Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026 

Figure 09: Middle East Veterinary Vaccines Market Y-o-Y Growth, 2015–2026 

Figure 10: Middle East Veterinary Vaccines Market Share Analysis (%) By Vaccine Type, 2016 & 2026

Figure 11: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Vaccine Type, 2015–2026 

Figure 12: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines Segment, 2015 – 2026

Figure 13: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines Segment, 2015 – 2026

Figure 14: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccine Segment, 2015 – 2026

Figure 15: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccine Segment, 2015 – 2026

Figure 16: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) Recombinant Vaccines s Segment, 2015 – 2026

Figure 17: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 18: Middle East Veterinary Vaccines Market Attractiveness Analysis By Vaccine Type, 2016–2026 

Figure 19: Middle East Veterinary Vaccines Market Share Analysis (%) By Animal Type, 2016 & 2026

Figure 20: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Animal Type, 2015–2026 

Figure 21: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Companion Animals Segment, 2015 – 2026

Figure 22: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Livestock Animals Segment, 2015 – 2026

Figure 23: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Equine Segment, 2015 – 2026

Figure 24: Middle East Veterinary Vaccines Market Attractiveness Analysis By Animal Type, 2016–2026 

Figure 25: Middle East Veterinary Vaccines Market Share Analysis (%) By Disease Indication, 2020 & 2026

Figure 26: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Disease Indication, 2015–2026 

Figure 27: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Foot and Mouth Disease  Segment, 2015 – 2026

Figure 28: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By New Castle Disease Segment, 2015 – 2026

Figure 29: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By PPRS Segment, 2015 – 2026

Figure 30: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Canine Parvovirus Segment, 2015 – 2026

Figure 31: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Brucellosis Segment, 2015 – 2026

Figure 32: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian Influenza Segment, 2015 – 2026

Figure 33: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 34: Middle East Veterinary Vaccines Market Attractiveness Analysis By Disease Indication, 2016–2026 

Figure 35: Middle East Veterinary Vaccines Market Share Analysis (%) By End User, 2020 & 2026

Figure 36: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By End User, 2015–2026 

Figure 37: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacies Segment, 2015 – 2026

Figure 38: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics  Segment, 2015 – 2026

Figure 39: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Private Veterinary Pharmacies  Segment, 2015 – 2026

Figure 40: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026

Figure 41: Middle East Veterinary Vaccines Market Attractiveness Analysis By End User, 2016–2026 

Figure 42: Middle East Veterinary Vaccines Market Share Analysis (%) By Country, 2016 & 2026

Figure 43: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 44: UAE Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),

Figure 45: KSA Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),

Figure 46: Turkey Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 47: Jordan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 48: Sudan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 49: Egypt Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 50: Rest of MEA

Figure 51: Middle East Veterinary Vaccines Market Attractiveness Analysis By Country, 2016–2026